LATVIJAS BIOMEDICINAS PETIJUMU UN STUDIJU CENTRS

Their core work

The Latvian Biomedical Research and Study Centre (LBMC) is a research institution in Riga focused on biobanking, genomics, and translational biomedicine. They work on integrating biobank data with omics and clinical datasets to advance precision medicine for metabolic and other disorders. Their capabilities span biospecimen management, data standardization (FAIR principles), and connecting laboratory research to clinical applications. They have also contributed to the European 1+ Million Genomes initiative, supporting cross-border genomic data infrastructure.

What they specialise in

How they've shifted over time

LBMC's early H2020 work (2015–2018) centred on foundational biobanking operations and public engagement — participating in the BBMRI-ERIC biobank gateway and hosting Researchers' Night events. From 2019 onward, their focus shifted decisively toward data-driven precision medicine: they coordinated INTEGROMED to integrate biobank, omics, and clinical data for personalised treatments, and joined the ambitious B1MG genomic data initiative. The trajectory shows a clear move from infrastructure participation to active leadership in translational genomic medicine.

LBMC is positioning itself as a bridge between biobank resources and clinical genomics, moving toward larger-scale European data-sharing initiatives — expect continued involvement in personalised medicine and genomic infrastructure projects.

How they like to work

LBMC operates primarily as a participant and specialist contributor, though they demonstrated coordination capability with INTEGROMED (their largest project at EUR 350,000). With 76 unique partners across 25 countries from just 4 projects, they are embedded in large, multi-national consortia rather than leading small focused teams. This broad network suggests they are well-connected within the European biomedical research community and comfortable working in complex, distributed partnerships.

Despite a small project portfolio, LBMC has built a remarkably wide network of 76 partners across 25 countries, reflecting participation in large pan-European health and data infrastructure consortia. Their geographic reach spans most of Europe with no strong regional cluster beyond the Baltic.

What sets them apart

LBMC brings a relatively rare combination for a Baltic institution: deep biobanking expertise paired with growing capability in genomic data integration and FAIR-compliant infrastructure. As a Latvian research centre active in flagship European genomics initiatives (BBMRI-ERIC, 1+MG), they offer consortium builders a credible Widening Country partner with genuine technical substance rather than token geographic coverage. Their coordination of INTEGROMED shows they can lead translational work connecting biobanks to clinical precision medicine.

Highlights from their portfolio

• INTEGROMED
  Their only coordinated project (EUR 350,000), demonstrating leadership in integrating biobank data with clinical studies for precision medicine in metabolic disorders.
• B1MG
  Participation in the high-profile Beyond 1 Million Genomes initiative positions LBMC within Europe's most ambitious genomic data-sharing effort.